BioSpace News Archive

IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring system that are designed for use during MRI procedures,

PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals as a very limited distribution partner for the novel drug GIVLAARI™ (givosiran)

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based and immunotherapeutic products for the treatment of cancer, today announced that its GD2-GD3 Vaccine has been granted a Rare Pediatric Disease Designation (“RPDD”) by the FDA for the treatment of neuroblastoma.

BioAegis Therapeutics, Inc., a clinical stage company developing technology to address injurious inflammation while protecting immune function and vital organs in diseases driven by inflammation and infection, announces publication of new research findings with recombinant human plasma gelsolin in influenza.

Shineco, Inc. announced that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd., has award an certificate from Trade & Association on November 29, 2019 to jointly establish industry hemp comprehensive utilization park in China.

Global Genes®, a leading rare disease patient advocacy organization, is proud to announce the 2020 RARE Patient Impact Grant recipients.

Growth charts, hormones, risky behaviors … pediatricians have a lot to cover in the 20 minutes they spend with their patients, and yet a simple conversation can help thwart a wayward youthful trajectory.

For people in the Mercer/Bucks County region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis and pulmonary fibrosis, Capital Health is launching its new Pulmonary Rehabilitation Program in December.

Company Started by NFL Chargers Hall of Famer Wes Chandler Collaborates with TSOI to Provide Nutraceutical Approach to Chronic Traumatic Encephalopathy

These certifications highlight the company’s relentless focus on security and compliance when it comes to the world’s most personal information: genomic data.